Gajjar A, Robinson GW, Smith KS, Lin T, et al. Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03). J Clin Oncol 2021 Jan 6:JCO2001372. doi: 10.1200/JCO.20.01372.
PMID: 33405951